GLUCOSYLCERAMIDE SYNTHASE INHIBITORS

The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors Good, Andrew, Makino, Elina, Cheng, Seng H, Husson, Herve, Leonard, John, Celatka, Cassandra, Marshall, John, Beskrovnaya, Oxana, Scheule, Ronald K, Xiang, Yibin, Skerlj, Renato, Jancsics, Katherine, Cabrera-Salazar, Mario A, Natoli, Thomas, Bourque, Elyse, Zhao, Zhong, Hirth, Bradford, Metz, Markus
Format Patent
LanguageCroatian
English
Published 13.05.2022
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
AbstractList The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage diseases, either alone or in combination with enzyme replacement therapy, cystic disease and for the treatment of cancer.
Author Hirth, Bradford
Husson, Herve
Bourque, Elyse
Scheule, Ronald K
Cheng, Seng H
Metz, Markus
Leonard, John
Beskrovnaya, Oxana
Makino, Elina
Xiang, Yibin
Natoli, Thomas
Skerlj, Renato
Zhao, Zhong
Jancsics, Katherine
Good, Andrew
Cabrera-Salazar, Mario A
Celatka, Cassandra
Marshall, John
Author_xml – fullname: Good, Andrew
– fullname: Makino, Elina
– fullname: Cheng, Seng H
– fullname: Husson, Herve
– fullname: Leonard, John
– fullname: Celatka, Cassandra
– fullname: Marshall, John
– fullname: Beskrovnaya, Oxana
– fullname: Scheule, Ronald K
– fullname: Xiang, Yibin
– fullname: Skerlj, Renato
– fullname: Jancsics, Katherine
– fullname: Cabrera-Salazar, Mario A
– fullname: Natoli, Thomas
– fullname: Bourque, Elyse
– fullname: Zhao, Zhong
– fullname: Hirth, Bradford
– fullname: Metz, Markus
BookMark eNrjYmDJy89L5WRQcfcJdfYPjvRxdg1y9PV0cVUIjvQL8XAMdlXw9PPwdPIM8Q8K5mFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8R5BAUYGRkYGxoYGISGGxsSpAgAoryZ5
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate INHIBITORI GLUKOZILCERAMID SINTAZE
ExternalDocumentID HRP20220310TT1
GroupedDBID EVB
ID FETCH-epo_espacenet_HRP20220310TT13
IEDL.DBID EVB
IngestDate Fri Aug 23 06:54:11 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Croatian
English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_HRP20220310TT13
Notes Application Number: HR2022P000310T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220513&DB=EPODOC&CC=HR&NR=P20220310T1
ParticipantIDs epo_espacenet_HRP20220310TT1
PublicationCentury 2000
PublicationDate 20220513
PublicationDateYYYYMMDD 2022-05-13
PublicationDate_xml – month: 05
  year: 2022
  text: 20220513
  day: 13
PublicationDecade 2020
PublicationYear 2022
RelatedCompanies Genzyme Corporation
RelatedCompanies_xml – name: Genzyme Corporation
Score 3.4061513
Snippet The invention relates to inhibitors of glucosylceramide synthase (GCS) of formula (I) useful for the treatment of metabolic diseases, such as lysosomal storage...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title GLUCOSYLCERAMIDE SYNTHASE INHIBITORS
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20220513&DB=EPODOC&locale=&CC=HR&NR=P20220310T1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSU0yS0kGpg1dC8PkFGAHJSVNF9hXMdJNTEtLTTFLSkxMTQGvtvAz8wg18YowjWBiyIbthQGfE1oOPhwRmKOSgfm9BFxeFyAGsVzAayuL9ZMygUL59m4hti5q0N4xaNeoobGai5Ota4C_i7-zmrOzrUeQml-QbQBYEtiWCQF2lVhB7WjQQfuuYU6gbSkFyHWKmyADWwDQuLwSIQamjCJhBk5n2NVrwgwcvtAZbyATmvmKRRhU3H1Cnf2DI32cXYMcfT1dXBWCI_1CPByDXRU8_Tw8nTxD_IOCRRmU3VxDnD10gdbFwz0X7xGEcFqIobEYAwuw258qwaCQnJScBgxAE8tUi2STJAOzpDQzYG1rYQkM3KRkc5M0SQYZfCZJ4ZeWZuAC8UDz4IbGMgwsJUWlqbLA6rUkSQ4cLADphXwv
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dT8IwEL8QNOKbosYPVBLJ3hadzAEPi4Fu2OnYyFYMPC2026IxUQIz_vtemyE-8db0kmt76fX6630UoJVxKxW4N_SuIVIEKGmuI1a51-d5nqUWn8-zVEVbBBadmM_Th2kFPta5MKpO6I8qjogaJVDfC3VeLzaPWI6KrVzd8nfs-nocMtvRSnQss0aNtuYMbHccOiHRCLFppAWRPVZEvMswhEo7HVmeV96dXgcyLWXx36YMD2B3jOw-i0OovC3rUCPrr9fqsDcqPd7YLJVvdQStJ39CwnjmEzfqjzzHbcazgNF-7Da9gHoDj4VRfAw3Q5cRquNwyd_iEhptpsaM9glUEfZnp9AUXOQoQLOXdYXJ7yyeW2htuz0ULhcdMz-DxjZO59vJ11CjbOQnvhe8XMC-pEifuNFuQLVYfmeXaGoLfqVE9AvgeX8c
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=GLUCOSYLCERAMIDE+SYNTHASE+INHIBITORS&rft.inventor=Good%2C+Andrew&rft.inventor=Makino%2C+Elina&rft.inventor=Cheng%2C+Seng+H&rft.inventor=Husson%2C+Herve&rft.inventor=Leonard%2C+John&rft.inventor=Celatka%2C+Cassandra&rft.inventor=Marshall%2C+John&rft.inventor=Beskrovnaya%2C+Oxana&rft.inventor=Scheule%2C+Ronald+K&rft.inventor=Xiang%2C+Yibin&rft.inventor=Skerlj%2C+Renato&rft.inventor=Jancsics%2C+Katherine&rft.inventor=Cabrera-Salazar%2C+Mario+A&rft.inventor=Natoli%2C+Thomas&rft.inventor=Bourque%2C+Elyse&rft.inventor=Zhao%2C+Zhong&rft.inventor=Hirth%2C+Bradford&rft.inventor=Metz%2C+Markus&rft.date=2022-05-13&rft.externalDBID=T1&rft.externalDocID=HRP20220310TT1